Moderna pitches virus vaccine at around $50-$60 per course - FT

Credit: REUTERS/Brian Snyder

Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course — higher than other vaccine makers have agreed to charge governments, the Financial Times reported on Tuesday.

July 28 (Reuters) - Moderna Inc MRNA.O is planning to price its coronavirus vaccine at $50 to $60 per course — higher than other vaccine makers have agreed to charge governments, the Financial Times reported on Tuesday.

The price would apply to the United States and other high-income countries, according to the report. https://on.ft.com/334eV4g

Moderna was not immediately available for comment.

(Reporting by Vishwadha Chander in Bengaluru; Editing by Maju Samuel)

((Vishwadha.Chander@thomsonreuters.com; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More